A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 2,101,038 shares of ARCT stock, worth $34 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
2,101,038
Previous 1,964,964 6.93%
Holding current value
$34 Million
Previous $47.8 Million 1.92%
% of portfolio
0.46%
Previous 0.44%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$18.08 - $25.38 $2.46 Million - $3.45 Million
136,074 Added 6.93%
2,101,038 $48.8 Million
Q2 2024

Jul 26, 2024

BUY
$24.35 - $44.39 $6.7 Million - $12.2 Million
275,315 Added 16.29%
1,964,964 $47.8 Million
Q1 2024

Apr 18, 2024

SELL
$31.23 - $42.99 $11.2 Million - $15.4 Million
-358,038 Reduced 17.48%
1,689,649 $57.1 Million
Q4 2023

Jan 17, 2024

BUY
$17.71 - $32.97 $2.59 Million - $4.82 Million
146,141 Added 7.69%
2,047,687 $64.6 Million
Q3 2023

Oct 18, 2023

SELL
$25.44 - $37.35 $138,648 - $203,557
-5,450 Reduced 0.29%
1,901,546 $48.6 Million
Q2 2023

Jul 10, 2023

SELL
$23.94 - $32.36 $1.88 Million - $2.54 Million
-78,425 Reduced 3.95%
1,906,996 $54.7 Million
Q1 2023

Apr 17, 2023

SELL
$14.72 - $23.97 $397,557 - $647,381
-27,008 Reduced 1.34%
1,985,421 $47.6 Million
Q4 2022

Jan 24, 2023

SELL
$14.14 - $23.06 $2.39 Million - $3.9 Million
-169,274 Reduced 7.76%
2,012,429 $0
Q3 2022

Oct 17, 2022

SELL
$13.05 - $22.13 $1.59 Million - $2.7 Million
-122,048 Reduced 5.3%
2,181,703 $32.3 Million
Q2 2022

Jul 11, 2022

SELL
$12.26 - $31.17 $981,891 - $2.5 Million
-80,089 Reduced 3.36%
2,303,751 $45.8 Million
Q1 2022

Apr 19, 2022

SELL
$17.64 - $39.57 $1.57 Million - $3.51 Million
-88,790 Reduced 3.59%
2,383,840 $64.3 Million
Q4 2021

Jan 28, 2022

SELL
$34.2 - $47.56 $1.95 Million - $2.71 Million
-56,879 Reduced 2.25%
2,472,630 $91.5 Million
Q3 2021

Nov 12, 2021

SELL
$27.88 - $58.25 $9.9 Million - $20.7 Million
-355,173 Reduced 12.31%
2,529,509 $121 Million
Q2 2021

Aug 05, 2021

SELL
$25.79 - $42.11 $11.5 Million - $18.8 Million
-447,207 Reduced 13.42%
2,884,682 $97.6 Million
Q1 2021

May 13, 2021

SELL
$38.75 - $86.92 $24.3 Million - $54.5 Million
-627,130 Reduced 15.84%
3,331,889 $138 Million
Q4 2020

Feb 12, 2021

BUY
$34.61 - $123.66 $50.6 Million - $181 Million
1,463,177 Added 58.62%
3,959,019 $172 Million
Q3 2020

Oct 30, 2020

BUY
$37.49 - $63.19 $21.6 Million - $36.5 Million
577,007 Added 30.07%
2,495,842 $107 Million
Q2 2020

Aug 11, 2020

BUY
$12.66 - $58.27 $4.49 Million - $20.6 Million
354,378 Added 22.65%
1,918,835 $89.7 Million
Q1 2020

May 14, 2020

BUY
$9.31 - $18.26 $1.68 Million - $3.3 Million
180,701 Added 13.06%
1,564,457 $21.3 Million
Q4 2019

Jan 31, 2020

BUY
$8.93 - $12.41 $976,432 - $1.36 Million
109,343 Added 8.58%
1,383,756 $15 Million
Q3 2019

Nov 12, 2019

BUY
$8.8 - $14.5 $2.38 Million - $3.92 Million
270,045 Added 26.89%
1,274,413 $13.1 Million
Q2 2019

Jul 30, 2019

BUY
$5.78 - $9.79 $5.81 Million - $9.83 Million
1,004,368 New
1,004,368 $9.48 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $430M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.